Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart
November 18, 2021 16:02 ET
|
Vaxart, Inc.
STANFORD, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- A new Stanford study published in Cell Host and Microbe has demonstrated that VXA-A1.1, an investigational oral tablet flu vaccine under...
Lateral Flow Assays Market revenue to cross USD 11.7 Bn by 2027: Global Market Insights Inc.
November 03, 2021 06:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The lateral flow assays market size is anticipated to record a valuation of USD 11.7 billion by 2027, according to the most recent study by...
7 Hills Pharma Announces the Completion of a Landmark Phase I Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
November 01, 2021 15:08 ET
|
7 Hills Pharma
HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), a clinical-stage drug development company bringing to market a platform of unique, first-in-concept oral small...
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021
October 21, 2021 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter...
Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day Conference
September 30, 2021 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the Guggenheim...
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
June 22, 2021 01:00 ET
|
Translate Bio, Inc.
-- Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise -- -- Positive preclinical safety and immunogenicity data...
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
June 21, 2021 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Vaccines Market Size to Reach USD 73.78 Billion in 2028; Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market, Says Reports and Data
June 02, 2021 13:43 ET
|
Reports and Data
New York, June 02, 2021 (GLOBE NEWSWIRE) -- Market Size – USD 42 Billion in 2020 Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global...
Vystar Partners with “Nothing in the Air” for RxAir Marketing, Advertising & Distribution
June 02, 2021 08:30 ET
|
Vystar Corp.
NITA president one of nation’s top 100 TV healthcare content producersLaunching ROKU Campaign June 3 Worcester, MA and PALM DESERT, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s...
Global Antiviral Therapies Market Expected to Surpass to $66,016.5 Million and Exhibit a CAGR of 3.1% from 2020 to 2027 - Exclusive Report [Pages - 208] by Research Dive
April 12, 2021 09:15 ET
|
Research Dive
New York, USA , April 12, 2021 (GLOBE NEWSWIRE) -- Research Dive in its latest published report estimates that the global antiviral therapies market will generate $66,016.5 million and exhibit...